Concepedia

Roberto Spreafico

RS

Statistics

Publications

60

Citations

9.1K

H-Index

41

Active since

2004

Affiliations

University of California, Los Angeles(Current)

QB3

University of Milano-Bicocca

VIR Biotechnology (United States)

Vir Biotechnology (Switzerland)

Roberto Spreafico is an author at University of California, Los Angeles specializing in life sciences, immunology, and molecular biology.

ORCID

Publications per year

2004–2025

60

Publications

60

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young‐Jun Park, Martina Beltramello et al. · Nature · 2020 · 2.2K citations · Full text

, , +10

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd et al. · Cell · 2021 · 657 citations · Full text

, , +15

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp et al. · Science · 2020 · 627 citations · Full text

, , +17

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

Ann M. Arvin, Katja Fink, Michael Schmid et al. · Nature · 2020 · 537 citations · Full text

, , +17

Type III interferons disrupt the lung epithelial barrier upon viral recognition

Achille Broggi, Sreya Ghosh, Benedetta Sposito et al. · Science · 2020 · 416 citations · Full text

, , +17

1–5 of 60